IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tim Eisen, MD
Addenbrooke's Hospital University of Cambridge, UK
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
105 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Saint André
Bordeaux, France
- Centre Francois Baclesse, Comite Urologie-Gynecologie
Caen, France
- Chu Estaing, Service D'Hematologie Clinique Adulte Et de Therapie Cellulaire
Clermont-Ferrand, France
- Hospital Européen Georges Pompidou, Service D'Oncologie Medicale
Paris, France
- Centre Rene Gauducheau, Service D'Oncologie Medicale
Saint-Herblain, France
- Universitätsmedizin Berlin, Charité Campus Benjamin Franklin, Urologische Klinik Und Hochschulambulanz
Berlin, Germany
- Klinik Für Hämatologie Und Internistische Onkologie, Augusta-Krankenanstalt Ggmbh
Bochum, Germany
- Medizinische Klinik Iii Für Hämatologie Und Onkologie, Universitätsklinikum Bonn
Bonn, Germany
- Universitätsklinikum Essen, Klinik Für Innere Medizin (tumorforschung)
Essen, Germany
- Klinik Für Hämatologie, Hämostaseologie, Onkologie Und Stammzelltransplantation, Medizinische Hochschule Hannover
Hanover, Germany
- Nationales Centrum Für Tumorerkrankungen (nct), Medizinische Onkologie
Heidelberg, Germany
- Klinik Und Poliklinik Für Urologie, Abteilung Für Operative Medizin, Universitätsklinikum Leipzig
Leipzig, Germany
- Klinikum Rechts Der Isar, Urologischen Klinik Und Poliklinik, Technische Universität München
Munich, Germany
- Urologische Klinik Dr. Castringius, München-Planegg
Planegg, Germany
- Klinikum St. Elisabeth Straubing Gmbh
Straubing, Germany
- Klinik Für Urologie, Universitätsklinikum Tübingen
Tübingen, Germany
- Klinik Für Innere Medizin Iii, Hämatologie - Onkologie - Rheumatologie - Infektionskrankheiten, Universitätsklinikum Ulm
Ulm, Germany
- Schwarzwald-Baar Klinikum Villingen-Schwenningen, Abteilung Hämatologie Und Onkologie
Villingen-Schwenningen, Germany
- Péterfy Utcai Hospital, Urology Department
Budapest, Hungary
- Semmelweis University, Urology Clinic
Budapest, Hungary
- Urology Department, Bajcsy-Zsilinszky Hospital
Budapest, Hungary
- Uzsoki Utcai Hospital, Oncoradiology Center
Budapest, Hungary
- Kenézy Hospital, Urology Department
Debrecen, Hungary
- University of Debrecen, Faculty of Medicine, Institute of Oncology
Debrecen, Hungary
- University of Debrecen, Faculty of Medicine, Urology Clinic
Debrecen, Hungary
- Oncology Centre, Markhot Ferenc Training Hospital and Clinic
Eger, Hungary
- Pándy Kálmán County Hospital, Oncology and Radiotherapy Center
Gyula, Hungary
- Urology Department, Baz County Hospital
Miskolc, Hungary
- Urology Clinic, University of Pécs
Pécs, Hungary
- Oncology Therapy Clinic, University of Szeged
Szeged, Hungary
- County Oncology Centre, Hetényi Géza Hospital
Szolnok, Hungary
- Oncology Department, Zala County Hospital
Zalaegerszeg, Hungary
- Presidio Ospedaliero Ospedale San Donato, U.O. Oncologia Medica
Arezzo, Italy
- Centro Di Riferimento Oncologico Di Aviano
Aviano, Italy
- Medical Oncology Unit, Policlinico Sant'Orsola Malpighi
Bologna, Italy
- Department of Oncology and Haematology, Division of Medical Oncology, University of Modena and Reggio Emilia
Modena, Italy
- Dipartimento Di Oncologia, Irccs Fondazione
Pavia, Italy
- Medical Oncology, Hospital Santa Maria Nuova of Reggio Emilia
Reggio Emilia, Italy
- Oncologia Medica, "ospedale Infermi"
Rimini, Italy
- Ospedale S.S Annunziata Sasari
Sassari, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 31 Jul 2015
- Completion
- 31 Jul 2015
- Last update posted
- 12 Oct 2017
- Registered enrollment
- 339
- Registry id
- NCT01265901
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.